Name: Pseudomonas aeruginosa Induced Lung Injury Model (Video) | JoVE Journal
Uploaded: 2014-10-29T15:00:00.000+00:00
Duration: 7 min 24 s
Description: Learn to establish a mouse pneumonia model using intra-tracheal Pseudomonas aeruginosa injection. This method enables researchers to study lung inflammation, cell death, and repair mechanisms in acute lung injury.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by National Institutes of Health grants HL105947-01 (YL), HL07829-16 (AM), HL090152 (AM).

The animal experiments were approved by the Animal Care Committee and Institutional Biosafety Committees of the University of Illinois at Chicago.
NOTE: All procedures involving pseudomonas should be performed with Biosafety Level 2 (BSL2) practices, which include but are not limited to: mask, eye protection, gown or jumpsuit, and double gloves. Work in certified Biosafety Cabinet. Treat instruments in contact with bacteria with bleach or chlorine dioxide based disinfectant. Use a sealed box for transport samples.
1. P. aeruginosa Culture and Growth
<ol>
	<li>Store P. aeruginosa PA103 as a bacterial stock in a screw cap cryovial at -80 &#176;C.</li>
	<li>Place the vial in a rack in a box with 70% ethanol wetted paper towels and take to the Biosafety Level 2 (BSL2) laboratory.</li>
	<li>Streak the bacteria onto sheep blood agar plates and grow at 37 &#176;C for ~15 hr in an incubator.</li>
	<li>In a BSL2 hood, scratch the bacteria from plate with bacteria loop and resuspend in 5 ml PBS.</li>
	<li>Store the stock at 4 &#176;C for up to 3 months. However, determine the titer every 2 weeks.</li>
	<li>Serially dilute the bacteria in PBS (usually from 1:104 to 1:107) and plate out the known dilution on sheep blood agar plates.</li>
	<li>Incubate the plates for ~15 hr. Count colonies and calculate Colony Forming Unit (CFU) to determine bacteria concentration.</li>
	<li>Resuspend the appropriate concentrations (~5 x 103 CFU/&#181;l) in 0.5 ml PBS in 1.5 ml sterile screw cap cryovials. Seal the cryovials and place them in a cryovial rack on disinfectant laden paper towels in a snap lid box.</li>
	<li>Transport the box to BSL2 animal facility. Once there, open the box in the BSL2 cabinet.</li>
</ol>
2. P. aeruginosa Instillation
<ol>
	<li>Perform survival surgery aseptically (sterile gloves, sterile instruments, and aseptic techniques). Use a sterile drape to provide a working surface for sterile (autoclaved) surgical instruments. Sterilize instruments using a hot bead sterilizer between each tracheal instillation procedure.</li>
	<li>Weigh mice prior to anesthetization. Anesthetize mice with ketamine (100 mg/kg), xylazine (5 mg/kg), in 0.1 - 0.2 ml PBS intraperitoneally (i.p.). Determine the effectiveness of the anesthetic by non-responsiveness to toe pinch. Use a vet ointment on eyes to prevent dryness under anesthesia.</li>
	<li>Restrain mice on a surgical board in BSL2 cabinet.</li>
	<li>Identify the area for the cut down. Shave this area and prepare the skin using alternating alcohol and povidone iodine swabs 3 times.</li>
	<li>Treat the incision area with local anesthetic (lidocaine) as this anesthesia is sufficient for a minor surgery such as a skin incision to access the trachea.</li>
	<li>Make a small incision (approximately 5 mm) at the midline of the neck, and use blunt forceps to gently move the muscle for access to the trachea. Expose the trachea by surgical dissection.</li>
	<li>Draw bacteria solution into a 1 ml disposable syringe with 27 G needle. For each mouse, administer 20-30 &#181;l of bacteria at the appropriate concentration (up to 105 CFU each mouse).</li>
	<li>Insert needle into the trachea. Inject solution slowly into the tracheal.</li>
	<li>Ensure that the animal gasps, which usually indicates that solution has reached into the lung.</li>
	<li>Close the wound with sterile sutures (6-0 monofilament) under aseptic conditions.</li>
	<li>Use 0.1 mg/kg buprenorphine by subcutaneous injection as post-op analgesia to control post-surgical pain.</li>
	<li>Ensure that the time required from initial anesthetic induction to incision closure is less than 15 min.</li>
	<li>After injection, dispose of syringes and needles in an appropriate biohazard sharps container.</li>
	<li>Treat the surgical instruments with chlorine dioxide based disinfectant for 15 min, rinse and return to the lab for sterilization and reuse as necessary.</li>
	<li>House the mice singly in clean cages at warm environment.</li>
	<li>Check on the animal every 30 min until it regains consciousness and starts to move; and later at 12 hr intervals for the first 3 days post-surgery.</li>
	<li>Keep the mice in the animal BSL2 facility throughout the experiment. Ensure that only tissue contained in sealed box leaves the animal BSL2 facility. If the mice express any of the moribund behaviors (defined as respiratory distress, lethargy, failure to ambulate in response to gentle stimulation) at any point in the study, euthanize the mice by CO2 inhalation from a bottled source followed by cervical dislocation.</li>
	<li>Euthanize the experimental subject by exsanguination under anesthesia.
	<ol>
		<li>Collect lung tissue from euthanized mice. Carry out these procedures in a BSL2 hood. If needed, transfer the sample using sealed tubes placed in a rack on disinfectant laden paper towels in a snap lid box for further process.</li>
	</ol>
	</li>
</ol>

<ol><li>Ware, L. B., Matthay, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+acute+respiratory+distress+syndrome%5BTitle%5D)+AND+%22N+Engl+J+Med%22%5BJournal%5D)">The acute respiratory distress syndrome.</a> N Engl J Med. 342, 1334-1349 (2000).</li>
<li>Matthay, M. A., Ware, L. B., Zimmerman, G. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+acute+respiratory+distress+syndrome%5BTitle%5D)+AND+%22J+Clin+Invest%22%5BJournal%5D)">The acute respiratory distress syndrome.</a> J Clin Invest. 122, 2731-2740 (2012).</li>
<li>Shimabukuro, D. W., Sawa, T., Gropper, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Injury+and+repair+in+lung+and+airways%5BTitle%5D)+AND+%22Crit+Care+Med%22%5BJournal%5D)">Injury and repair in lung and airways.</a> Crit Care Med. 31 (8), 524-531 (2003).</li>
<li>Wansleeben, C., Barkauskas, C. E., Rock, J. R., Hogan, B. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Stem+cells+of+the+adult+lung%3A+Their+development+and+role+in+homeostasis%2C+regeneration%2C+and+disease%5BTitle%5D)+AND+%22Wiley+Interdiscip+Rev+Dev+Biol%22%5BJournal%5D)">Stem cells of the adult lung: Their development and role in homeostasis, regeneration, and disease.</a> Wiley Interdiscip Rev Dev Biol. 2, 131-148 (2013).</li>
<li>Singleton, P. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Dynamin+2+and+c-abl+are+novel+regulators+of+hyperoxia-mediated+nadph+oxidase+activation+and+reactive+oxygen+species+production+in+caveolin-enriched+microdomains+of+the+endothelium%5BTitle%5D)+AND+%22J+Biol+Chem%22%5BJournal%5D)">Dynamin 2 and c-abl are novel regulators of hyperoxia-mediated nadph oxidase activation and reactive oxygen species production in caveolin-enriched microdomains of the endothelium.</a> J Biol Chem. 284, 34964-34975 (2009).</li>
<li>Sadikot, R. T., Blackwell, T. S., Christman, J. W., Prince, A. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pathogen-host+interactions+in+pseudomonas+aeruginosa+pneumonia%5BTitle%5D)+AND+%22Am+J+Respir+Crit+Care+Med%22%5BJournal%5D)">Pathogen-host interactions in pseudomonas aeruginosa pneumonia.</a> Am J Respir Crit Care Med. 171, 1209-1223 (2005).</li>
<li>Liu, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Foxm1+mediates+the+progenitor+function+of+type+ii+epithelial+cells+in+repairing+alveolar+injury+induced+by+pseudomonas+aeruginosa%5BTitle%5D)+AND+%22J+Exp+Med%22%5BJournal%5D)">Foxm1 mediates the progenitor function of type ii epithelial cells in repairing alveolar injury induced by pseudomonas aeruginosa.</a> J Exp Med. 208, 1473-1484 (2011).</li>
<li>Kurahashi, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pathogenesis+of+septic+shock+in+pseudomonas+aeruginosa+pneumonia%5BTitle%5D)+AND+%22J+Clin+Invest%22%5BJournal%5D)">Pathogenesis of septic shock in pseudomonas aeruginosa pneumonia.</a> J Clin Invest. 104, 743-750 (1999).</li>
<li>Kumar, P. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Distal+airway+stem+cells+yield+alveoli+in+vitro+and+during+lung+regeneration+following+h1n1+influenza+infection%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Distal airway stem cells yield alveoli in vitro and during lung regeneration following h1n1 influenza infection.</a> Cell. 147, 525-538 (2011).</li>
<li>Delano, M. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Sepsis+induces+early+alterations+in+innate+immunity+that+impact+mortality+to+secondary+infection%5BTitle%5D)+AND+%22J+Immunology%22%5BJournal%5D)">Sepsis induces early alterations in innate immunity that impact mortality to secondary infection.</a> J Immunology. 186, 195-202 (2011).</li>
<li>Lange, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+murine+model+of+sepsis+following+smoke+inhalation+injury%5BTitle%5D)+AND+%22Biochem+Biophys+Res+Commun%22%5BJournal%5D)">A murine model of sepsis following smoke inhalation injury.</a> Biochem Biophys Res Commun. 391 (3), 1555-1560 (2010).</li>
<li>Kobayashi, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+role+of+chemokines+in+neutrophil+biology%5BTitle%5D)+AND+%22Front+Biosci%22%5BJournal%5D)">The role of chemokines in neutrophil biology.</a> Front Biosci. 13, 2400-2407 (2008).</li>
<li>Matute-Bello, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Animal+models+of+acute+lung+injury%5BTitle%5D)+AND+%22Am+J+Physiol+Lung+Cell+Mol+Physiol%22%5BJournal%5D)">Animal models of acute lung injury.</a> Am J Physiol Lung Cell Mol Physiol. 295, L379-L399 (2008).</li>
<li>Sadikot, R. T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Targeted+immunomodulation+of+the+nf-kappab+pathway+in+airway+epithelium+impacts+host+defense+against+pseudomonas+aeruginosa%5BTitle%5D)+AND+%22J+Immunol%22%5BJournal%5D)">Targeted immunomodulation of the nf-kappab pathway in airway epithelium impacts host defense against pseudomonas aeruginosa.</a> J Immunol. 176, 4923-4930 (2006).</li>
<li>Pinto, I. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Development+of+an+experimental+model+of+neutrophilic+pulmonary+response+induction+in+mice%5BTitle%5D)+AND+%22J+Pneumologia%22%5BJournal%5D)">Development of an experimental model of neutrophilic pulmonary response induction in mice.</a> J Pneumologia. 29, 213-214 (2003).</li>
</ol>

The authors have nothing to disclose.

The Pseudomonas mouse lung injury model that we describe here mimics the whole process of inflammation, lung injury, repair, and resolution that occur following acute lung injury or pneumonia. It has unique advantages comparing with several other injury models in that it is clinically relevant and relatively safe and easy to handle.
The critical step in the procedure is that the injection of bacteria solution needs to be very slow. If injection is too fast, the mice are likely to die by choke....

Lungs are exposed to environmental pathogens and are susceptible to inflammation and injury1-3. During pathological conditions such as pneumonia or Adult Respiratory Distress Syndrome (ARDS), pathogens as well as inflammatory factors released by leukocytes induce injury and death of alveolar cells1-3. It is important to develop animal models of acute lung injury to facilitate the study of pathology of injury as well as mechanism of repair.
Currently, most people use hyperoxia and bleomycin induced mouse lung injury models4. However, the mechanisms of hyperoxia caused injury are not the same as most common lung injuries that occur during pneumonia or ARDS5. Bleomycin induced acute injury is rare in a clinical context4. Here we report a mouse lung injury model using intra-tracheal injection of P. aeruginosa 6,7. This model is clinically relevant, and mimics the processes that happen following pneumonia8.
As an opportunistic, nosocomial pathogen of immunocompromised individuals, P. aeruginosa typically infects the pulmonary tract, urinary tract, burns, wounds, and also causes other blood infections6. The bacteria release virulence factor exotoxin A, multiply and trigger immune responses6. Intra-trachael administration of P. aeruginosa reflects the situation in human exposure to the bacteria which cause pneumonia and the pathology is likely to be different from the recently reported influenza virus H1N1 induced lung injury model9. Since P. aeruginosa is an opportunistic pathogen, it is relatively safe to handle as compared to some of the more virulent pathogens. &#160;Here we used intra-tracheal injection to administer the bacteria because we observed that this method introduced more bacteria into the distal alveoli region of the lung compared with some other procedures such as using a catheter via mouth.
Compared with other acute lung injury models, the P. aeruginosa model described here is suitable for studying lung injury induced by bacteria and by excessive inflammation. Unlike other animal models that use P. aeruginosa to induce sepsis10,11, here we use intra-tracheal injection of these bacteria to induce localized acute lung injury.

<table><tbody><tr><td>Anesthetic: Ketamin, xylazine, lidocaine, buprenorphine</td><td></td><td></td><td>pharmaceutical grade</td></tr><tr><td>27 G needle</td><td>Fisher</td><td>1482648</td><td></td></tr><tr><td>syringe</td><td>Fisher</td><td>14823434</td><td>1 ml</td></tr><tr><td>scissors</td><td>Fine Science tools</td><td></td><td></td></tr><tr><td>forceps</td><td>Fine Science tools</td><td></td><td></td></tr><tr><td>suture&amp;nbsp;</td><td>Fisher</td><td>19-037-526</td><td></td></tr><tr><td>Eye gauge, glove, gown</td><td></td><td></td><td></td></tr><tr><td>Biosafety Cabinet</td><td></td><td></td><td></td></tr><tr><td>chlorine dioxide based disinfectant</td><td></td><td></td><td>Clidox</td></tr><tr><td>sheep blood agar plates&amp;nbsp;</td><td>Medex supply</td><td>HL-1160</td><td></td></tr></tbody></table>

pseudomonas aeruginosa induced lung injury model

Pseudomonas aeruginosa Induced Lung Injury Model

In order to study human acute lung injury and pneumonia, it is important to develop animal models to mimic various pathological features of this disease. Here we have developed a mouse lung injury model by intra-tracheal injection of bacteria Pseudomonas aeruginosa (P. aeruginosa or PA). Using this model, we were able to show lung inflammation at the early phase of injury. In addition, alveolar epithelial barrier leakiness was observed by analyzing bronchoalveolar lavage (BAL); and alveolar cell death was observed by Tunel assay using tissue prepared from injured lungs. At a later phase following injury, we observed cell proliferation required for the repair process. The injury was resolved 7 days from the initiation of P. aeruginosa injection. This model mimics the sequential course of lung inflammation, injury and repair during pneumonia. This clinically relevant animal model is suitable for studying pathology, mechanism of repair, following acute lung injury, and also can be used to test potential therapeutic agents for this disease.

Starting from 24 - 72 hr post P. aeruginosa injection, increased cellularity was observed in lung sections (Figure 1A-D). The lung started to recover from 96 hr post injury (Figure 1E). At 7 days post P. aeruginosa, normal alveoli morphology was largely restored (Figure 1F). Tunnel staining using lung sections prepared at 24 hr post P. aeruginosa showed cell death in alveoli cells (Figure 1G-I). In order to study the repair pro...

We have developed a mouse lung injury model by intra-tracheal injection of bacteria Pseudomonas aeruginosa. This model mimics lung injury during pneumonia and is clinically relevant.

In order to study human acute lung injury and pneumonia, it is important to develop animal models to mimic various pathological features of this disease. ...

pseudomonas-aeruginosa-induced-lung-injury-model

Research

JoVE Journal

Immunology and Infection

We describe the agar-beads method to establish persistent long-term chronic Pseudomonas aeruginosa airway infection in the mouse model.

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

We describe a method for inducing neutrophilic pulmonary inflammation by challenge to aerosolized lipopolysaccharide by nebulization, to model acute lung injury. In addition, basic surgical techniques for lung isolation, tracheal intubation and bronchoalveolar lavage are also described.

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

While in vitro study of host-pathogen interactions allow the characterization of specific immune responses, in vivo models are required to observe the effects of complex responses. Using Candida albicans exposure followed by Pseudomonas aeruginosa-mediated lung infection, we established a murine model of microbial interactions involved in ventilator-associated pneumonia pathogenicity.

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Several methods have been described in the literature for modeling bacterial pneumonia in mice. Herein, we describe a non-invasive, inexpensive, rapid method for inducing pneumonia via aspiration (i.e., inhalation) of a bacterial inoculum pipetted into the oropharynx. Downstream methods for assessment of the pulmonary innate immune response are also detailed.

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

A method for establishing lung infections in immunocompetent rodents is described. With proficiency, this method can be performed quickly and easily to induce stable infection with many isolates of S. pneumoniae, H. influenzae, P. aeruginosa, K. pneumoniae and A. baumannii.

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Simple methods are described for demonstrating the production of cytotoxic amyloids following infection of pulmonary endothelium by Pseudomonas aeruginosa.

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Presented here is a step-by-step procedure to induce acute lung injury in mice by direct intratracheal lipopolysaccharide instillation and to perform FACS analysis of blood samples, bronchoalveolar lavage fluid, and lung tissue. Minimal invasiveness, simple handling, good reproducibility, and titration of disease severity are advantages of this approach.

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

We describe a delayed inoculation protocol for generating chronic wound infections in immunocompetent mice.

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

This manuscript describes the establishment of an infectious model of pneumonia in mice and the respective characterization of injury resolution along with methods for growing bacteria and intratracheal instillation. A novel approach using high-dimensional flow cytometry to evaluate the immune landscape is also described.

Experimental Model to Evaluate Resolution of Pneumonia

There is currently a lack of in vivo models amenable to drug screening against chronic bacterial infections. Here, we describe a protocol for wound infection by a Pseudomonas aeruginosa clinical isolate to generate a persistent infection in zebrafish larvae.

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae

In this study, a non-invasive endotracheal instillation technique is demonstrated to develop ALI in rats using a basic laryngoscope to ensure precise LPS delivery to the lungs. The LPS is instilled via an endotracheal tube using a laryngoscope. The magnitude of lung injury is evaluated at multiple time points.

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents

Learn to establish a mouse pneumonia model using intra-tracheal Pseudomonas aeruginosa injection. This method enables researchers to study lung inflammation, cell death, and repair mechanisms in acute lung injury.

Pseudomonas aeruginosa Induced Lung Injury Model

Explore More Videos